Association of DJ-1/PTEN/AKT- and ASK1/p38-mediated cell signalling with ischaemic cardiomyopathy

Cardiovascular Research

Volumn 97, Issue 1, 2013, Pages 66-76

  Klawitter, Jelena ^a   Klawitter, Jost ^a   Agardi, Erika ^a   Corby, Kyler ^a   Leibfritz, Dieter ^b   Lowes, Brian D ^c,d   Christians, Uwe ^a   Seres, Tamas ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BREMEN   (Germany)

^c UNIVERSITY OF COLORADO   (United States)

^d NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cardiomyopathy; Cell signaling; IDCM; ISCM; Metabolomics; Proteomics

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; ASPARTIC ACID; DJ 1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KETONE BODY; MALIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDYLPROLYL ISOMERASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

AMINO ACID TRANSPORT; ARTICLE; CITRIC ACID CYCLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; ENZYME PHOSPHORYLATION; FATTY ACID METABOLISM; FUNCTIONAL PROTEOMICS; GLUCOSE METABOLISM; GLYCOLYSIS; HEART MUSCLE METABOLISM; HUMAN; HUMAN TISSUE; IDIOPATHIC CARDIOMYOPATHY; IDIOPATHIC DISEASE; INTRACELLULAR SIGNALING; ISCHEMIC CARDIOMYOPATHY; METABOLOMICS; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSCRIPTION REGULATION;

BLOTTING, WESTERN; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CYTOSKELETON; ENERGY METABOLISM; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MAP KINASE KINASE KINASE 5; MASS SPECTROMETRY; METABOLOMICS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; ONCOGENE PROTEINS; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION;

EID: 84871792813     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs302     Document Type: Article

References (50)

1. Chien KR. Genomic circuits and the integrative biology of cardiac diseases. Nature 2000;407:227-232.
2. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002;106:3068-3072. (Pubitemid 35440290)
3. Chien KR. Stress pathways and heart failure. Cell 1999;98:555-558. (Pubitemid 29418947)
4. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994;331:1564-1575. (Pubitemid 24366905)
5. Olson EN. A decade of discoveries in cardiac biology. Nat Med 2004;10:467-474. (Pubitemid 38667903)
6. Barth AS, Kuner R, Buness A, Ruschhaupt M, Merk S, Zwermann L et al. Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies. J Am Coll Cardiol 2006;48:1610-1617. (Pubitemid 44528176)
7. Nanni L, Romualdi C, Maseri A, Lanfranchi G. Differential gene expression profiling in genetic and multifactorial cardiovascular diseases. J Mol Cell Cardiol 2006;41:934-948. (Pubitemid 44791333)
8. Haddad GE, Saunders LJ, Crosby SD, Carles M, del Monte F, King K et al. Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences. Physiol Genomics 2008;33:267-277. (Pubitemid 351629534)
9. Yung CK, Halperin VL, Tomaselli GF, Winslow RL. Gene expression profiles in endstage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. Genomics 2004;83:281-297. (Pubitemid 38050117)
10. Tsagalou EP, Anastasiou-Nana MI, Terrovitis JV, Nanas SN, Alexopoulos GP, Kanakakis J et al. The long-term survival benefit conferred by intermittent dobutamine infusions and oral amiodarone is greater in patients with idiopathic dilated cardiomy-opathy than with ischemic heart disease. Int J Cardiol 2006;108:244-250. (Pubitemid 43330621)
11. Bart BA, Shaw LK, McCants CB Jr, Fortin DF, Lee KL, Califf RM et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonis-chemic cardiomyopathy. J Am Coll Cardiol 1997;30:1002-1008. (Pubitemid 27435894)
12. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL et al. Underlying causes and long-term survival in patients with initially unexplained cardio-myopathy. N Engl J Med 2000;342:1077-1084. (Pubitemid 30207690)
13. Tentolouris C, Tousoulis D, Antoniades C, Bosinakou E, Kotsopoulou M, Trikas A et al. Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. Int J Cardiol 2004;94:301-305. (Pubitemid 38490677)
14. Xu L, Eu JP, Meissner G, Stamler JS. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 1998;279:234-237. (Pubitemid 28103882)
15. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002;105:1429-1435. (Pubitemid 34263273)
16. Ashrafian H, Frenneaux MP, Opie LH. Metabolic mechanisms in heart failure. Circulation 2007;116:434-448. (Pubitemid 47196549)
17. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med 2007;356:1140-1151. (Pubitemid 46425598)
18. Klawitter J, Kominsky DJ, Brown JL, Klawitter J, Christians U, Leibfritz D et al. Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells. Br J Pharmacol 2009;158:588-600.
19. Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G et al. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 2003;12:1413-1426. (Pubitemid 38037011)
20. Sabatine MS, Liu E, Morrow DA, Heller E, McCarroll R, Wiegand R et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 2005;112:3868-3875. (Pubitemid 43739484)
21. Zhou L, Yu X, Cabrera ME, Stanley WC. Role of cellular compartmentation in the metabolic response to stress: mechanistic insights from computational models. Ann NY Acad Sci 2006;1080:120-139. (Pubitemid 44955418)
22. Choy PC, Chan M, Hatch G, Man RY. Phosphatidylcholine metabolism in ischemic and hypoxic hearts. Mol Cell Biochem 1992;116:53-58.
23. Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 2004;95:135-145. (Pubitemid 38988679)
24. Bittl JA, Ingwall JS. Reaction rates of creatine kinase and ATP synthesis in the isolated rat heart. A 31P NMR magnetization transfer study. J Biol Chem 1985;260:3512-3517. (Pubitemid 15114351)
25. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005; 115:500-508. (Pubitemid 40322219)
26. Ingwall JS, Kramer MF, Fifer MA, Lorell BH, Shemin R, Grossman W et al. The creatine kinase system in normal and diseased human myocardium. N Engl J Med 1985;313:1050-1054. (Pubitemid 16243332)
27. Liao R, Nascimben L, Friedrich J, Gwathmey JK, Ingwall JS. Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. Circ Res 1996;78:893-902. (Pubitemid 26131374)
28. Endo J, Sano M, Katayama T, Hishiki T, Shinmura K, Morizane S et al. Metabolic remodeling induced by mitochondrial aldehyde stress stimulates tolerance to oxidative stress in the heart. Circ Res 2009;105:1118-1127.
29. Brixius K, Schwinger RH, Hoyer F, Napp A, Renner R, Bolck B et al. Isoform-specific downregulation of peroxiredoxin in human failing myocardium. Life Sci 2007;81:823-831. (Pubitemid 47332513)
30. Wood ZA, Schroder E, Robin HJ, Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 2003;28:32-40. (Pubitemid 36051004)
31. Kisucka J, Chauhan AK, Patten IS, Yesilaltay A, Neumann C, Van Etten RA et al. Per-oxiredoxin1 prevents excessive endothelial activation and early atherosclerosis. Circ Res 2008;103:598-605.
32. De Souza AI, Wait R, Mitchell AG, Banner NR, Dunn MJ, Rose ML. Heat shock protein 27 is associated with freedom from graft vasculopathy after human cardiac transplantation. Circ Res 2005;97:192-198. (Pubitemid 41033476)
33. Suurmeijer AJ, Clement S, Francesconi A, Bocchi L, Angelini A, Van Veldhuisen DJ et al. Alpha-actin isoform distribution in normal and failing human heart: a morphological, morphometric, and biochemical study. J Pathol 2003;199:387-397. (Pubitemid 36266862)
34. Kim RH, Peters M, Jang Y, Shi W, Pintilie M, Fletcher GC et al. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 2005;7:263-273. (Pubitemid 40568685)
35. Heling A, Zimmermann R, Kostin S, Maeno Y, Hein S, Devaux B et al. Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res 2000;86:846-853. (Pubitemid 30246981)
36. Chalothorn D, Zhang H, Smith JE, Edwards JC, Faber JE. Chloride intracellular channel-4 is a determinant of native collateral formation in skeletal muscle and brain. Circ Res 2009;105:89-98.
37. Littler DR, Harrop SJ, Goodchild SC, Phang JM, Mynott AV, Jiang L et al. The enigma of the CLIC proteins: ion channels, redox proteins, enzymes, scaffolding proteins? FEBS Lett 2010; 584:2093-2101.
38. Aleyasin H, Rousseaux MW, Phillips M, Kim RH, Bland RJ, Callaghan S et al. The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage. Proc Natl Acad Sci USA 2007;104:18748-18753. (Pubitemid 350210768)
39. Yanagida T, Tsushima J, Kitamura Y, Yanagisawa D, Takata K, Shibaike T et al. Oxida-tive stress induction of DJ-1 protein in reactive astrocytes scavenges free radicals and reduces cell injury. Oxid Med Cell Longev 2009;2:36-42.
40. Mukherjee UA, Ong SB, Davidson SM, Yellon DM, Hausenloy DJ. 37 A novel role for DJ-1 in cardioprotection. Heart 2011;97:e8.
41. Yang YJ, Zhu WL, Zhang X, Zhou XW, Zhu ZM. PTEN/PI3K pathways are involved in the signal transduction of myocardial remodeling in patients with congestive heart failure]. Zhonghua Yi Xue Za Zhi 2005;85:1201-1204. (Pubitemid 40691975)
42. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006;7:589-600. (Pubitemid 44325350)
43. Takeishi Y, Huang Q, Abe J, Che W, Lee JD, Kawakatsu H et al. Activation of mitogen-activated protein kinases and p90 ribosomal S6 kinase in failing human hearts with dilated cardiomyopathy. Cardiovasc Res 2002;53:131-137. (Pubitemid 34020773)
44. Oudit GY, Kassiri Z, Zhou J, Liu QC, Liu PP, Backx PH et al. Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to bio-mechanical stress. Cardiovasc Res 2008;78:505-514. (Pubitemid 351769769)
45. Liu Q, Wilkins BJ, Lee YJ, Ichijo H, Molkentin JD. Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth. Mol Cell Biol 2006;26:3785-3797. (Pubitemid 43726396)
46. Kim AH, Khursigara G, Sun X, Franke TF, Chao MV. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol 2001;21:893-901. (Pubitemid 32104737)
47. Zhang R, Luo D, Miao R, Bai L, Ge Q, Sessa WC et al. Hsp90-Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis. Oncogene 2005;24:3954-3963. (Pubitemid 40896407)
48. Golden T, Swingle M, Honkanen RE. The role of serine/threonine protein phosphat-ase type 5 (PP5) in the regulation of stress-induced signaling networks and cancer. Cancer Metastasis Rev 2008;27:169-178.
49. Atkinson GP, Nozell SE, Harrison DK, Stonecypher MS, Chen D, Benveniste EN. The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma. Oncogene 2009;28:3735-3745.
50. Kratsios P, Huth M, Temmerman L, Salimova E, Al Banchaabouchi M, Sgoifo A et al. Antioxidant amelioration of dilated cardiomyopathy caused by conditional deletion of NEMO/IKKgamma in cardiomyocytes. Circ Res 2010; 106:133-144.